Attached files

file filename
EX-99.1 - PRESS RELEASE DATED JANUARY 27, 2014 - Covidien plccov201401272014_ex991-01.htm


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 

FORM 8-K
 
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 21, 2014


COVIDIEN PUBLIC LIMITED COMPANY
(Exact name of registrant as specified in its charter)
 
 

 
 
 
 
 
 
Ireland
001-33259
98-0624794
(State or other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: +353 (1) 438-1700
 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 






 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 21, 2014, the Company’s Chief Financial Officer, Charles J. Dockendorff, notified the Company of his decision to retire from the Company at the end of calendar year 2014.
A copy of the press release announcing Mr. Dockendorff’s decision to retire is filed herewith as Exhibit 99.1.
Item 9.01.
Financial Statements and Exhibits.

(d)    Exhibits

99.1    Press Release dated January 27, 2014






 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
COVIDIEN PUBLIC LIMITED COMPANY
 
 
By:
 
/s/ John W. Kapples
 
 
John W. Kapples
 
 
Vice President and Corporate Secretary
Date: January 27, 2014






EXHIBIT INDEX

Exhibit No.
 
Exhibit Name
 
 
 
 
 
99.1
 
Press release dated January 27, 2014